See Table 5 and 6 for results from both studies.

The nonclinical toxicity profile of mycophenolate mofetil appears to be consistent with adverse events observed in human clinical trials which now provide safety data of more relevance to the patient population (see section 4.8).

35 human clinical trials which now provide safety data of more relevance to the patient population (see section 4.8).

Gastrointestinal and renal effects consistent with dehydration were also observed in the monkey at the highest dose (systemic exposure levels equivalent to or greater than clinical exposure). The nonclinical toxicity profile of mycophenolate mofetil appears to be consistent with adverse events observed in human clinical trials which now provide safety data of more relevance to the patient population (see section 4.8).

Information to be included in the procurement documents relating to electronic auctions (Article 35(4))

Information to be included in the results of design contest notices (as referred to in Article 96(1))

No HBV mutations associated with tenofovir disoproxil fumarate resistance have been identified (see Clinical results).

The pharmacokinetic results reflect the slightly different in vitro characteristics of these nebulizers (see Section 4.2).

(See Report on the Implementation of the European Year of Languages (COM (2002) 597).

Article 78 Scope

Pharmacokinetic analysis revealed that adefovir exposure was comparable among 3 age groups, 2 to 6 years (0.3 mg kg), 7 to 11 years (0.25 mg kg) and 12 to 17 years (10 mg) and all age groups achieved adefovir exposure in the target range (for efficacy results see section 5.1), which was based on adefovir plasma concentrations in adult patients with chronic hepatitis B with established safety and efficacy profiles.

The same results were confirmed in patients that were unsuitable for other systemic therapies (see Table 1 below).

The results indicate that XELOX is equivalent to FOLFOX 4 in terms of overall survival (see Table 7).

The results indicate that XELOX is equivalent to FOLFOX 4 in terms of overall survival (see Table 8).

Non clinical data reveal no special hazard for humans based on general safety studies (see section 4.6).

Results from animal studies further indicate that sorafenib can impair male and female fertility (see section 5.3).

Results of these studies indicate that no dosage adjustment is necessary for patients with hepatic impairment (see section 4.2).

Cardiorenal adverse events were observed more frequently with etoricoxib than with diclofenac, and this effect was dose dependent (see specific results below).

It will build on and strengthen research in the area of water pricing that was already supported by the 4th EU Framework Programme as illustrated in Box 5.

In 2006, Stuck raced in the inaugural season of the Grand Prix Masters formula for retired Formula One drivers after scoring 6th in the first race event at the Kyalami circuit in South Africa on 11 13 November 2005.

Based on these pharmacokinetic results co administration of sildenafil with ritonavir is contraindicated in pulmonary arterial hypertension patients (see section 4.3).

Based on non clinical findings, male and female fertility may be compromised by treatment with SUTENT (see section 5.3).

He was also Grand Marshal of the 1980 United States Grand Prix at Watkins Glen.

Also Lill Lövis does expert commentary on Viasat Motor during Formula One races on occasion.

For a survey of the ecological condition of the Elbe with reference to the pollution in the catchment area and the results and objectives of the Elbe clean up operation see Die Bewirtschaftung des Flußgebietes der Elbe in der DDR published by the Ministry for Nature and Environmental Protection and Water Resources of the GDR, February 1990 See footnote 6 Konzeption für die Entwicklung der Umweltpoli ti k, op. cit., p. 28 ÖIW, series 36 90, op. cit., p.

Results

Results

Results

0.8

submitted

Results abtained with this method

Conclusions

Outcomes

V. A PEOPLE'S EUROPE

ACHIEVEMENTS TO DATE

ACHIEVEMENTS

OUTPUT

Profit and loss

Similarly close follow up is needed in the four priority action areas (see Section 3) which the European Council agreed should be delivered by the end of 2007.

P.O. Box 101139, D 40002, Düsseldorf, Germany, Tel 49 211 6214215, Fax 49 211 6214 161, Email rosenzweig vdi.de, Internet http www. ima t. maschi nen bau.unikassel.de hms2001 index.html on the report and

see Annex II Vigabatrin see Annex II see Annex II see Annex II see Annex II

The sample or group receiving the drug would be the experimental group (treatment group) and the one receiving the placebo or regular treatment would be the control one.

The significance of these data in pregnant women is not known therefore the use of AMMONAPS is contra indicated during pregnancy (see section 4.3).

Chlormezanone see Annex A see Annex A see Annex A see Annex A

Impressive results.